Collectively, these results demonstrated that there is an intensive connection between the serum metabolic disorder and the gut microbiota dysbiosis caused by SIRT2 deficiency, the interplay of which may contribute to NAFLD progression. This evidence concerns the gene SIRT2 and metabolic dysfunction-associated steatotic liver disease.